Jeffrey Clothier
Sourced from institutional research profiles (UAMS TRI or ARA).
Researcher
Also affiliated: Veterans Health Administration (1999); Harris County Department of Education (1991); Psychiatric Medical Center (2017–2022); The University of Texas at Austin (1984)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Jeffrey Clothier's research focuses on genetics and its relationship to neurological and psychiatric conditions, particularly in children. His work includes investigating the molecular underpinnings of Autism Spectrum Disorder (ASD) and intellectual disability, as seen in his identification of DCAF1 as a candidate gene for these conditions. Clothier also studies rare genetic disorders, such as White-Sutton Syndrome, and their associated clinical presentations, including catatonia. He has explored the implementation of pharmacogenomics testing in a clinical setting, specifically at Arkansas Children's Hospital. His publications also touch upon the successful treatment of complex neurological cases, such as catatonia with central nervous system autoantibodies, using high-dose immunoglobulin therapy. Clothier has a h-index of 6 with 19 total publications and 247 citations.
Metrics
- h-index: 6
- Publications: 19
- Citations: 248
Selected Publications
-
165. Bridging Genetics and Psychiatry: ARID1B Haploinsufficiency in Autism Spectrum Disorder and Its Implications for C-L Psychiatry (2025)
-
Lessons from an MD PhD – From SLC13A5 to Neurology (2023)
-
Successful Treatment with High-Dose Immunoglobulin of a Complicated Patient with Catatonia and Central Nervous System Autoantibodies (2023)
-
Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report (2022)
-
Molecular Dysregulation in Autism Spectrum Disorder (2021)
-
Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital (2021)
-
Metformin, valproic acid, and starvation induce seizures in a patient with partial SLC13A5 deficiency: a case of pharmaco-synergistic heterozygosity (2020)
-
Buprenorphine use for pain and suicidal ideation in severely suicidal patients (2020)
-
Case Series: Choreoathetoid movements associated with methamphetamine: A case report and review of literature (2018)
-
Phelan‐McDermid syndrome and cancer predisposition: The value of a karyotype (2017)
-
Response to unfairness across the suicide risk spectrum (2017)
-
600. Resting State fMRI of Raphe Nucleus Activity following Ketamine (2017)
-
Association between C-reactive protein and suicidal behavior in an adult inpatient population (2016)
-
Medical Student Attitudes and Knowledge About ECT (2001)
-
Impact of travel distance on the disposition of patients presenting for emergency psychiatric care (1999)
Grants & Funding
As listed on this researcher's institutional profile.
- Bupropion for Depression in ESRD Patients on Hemodialysis NIH
Collaboration Network
Top Collaborators
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Molecular Dysregulation in Autism Spectrum Disorder
- Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Molecular Dysregulation in Autism Spectrum Disorder
- Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Molecular Dysregulation in Autism Spectrum Disorder
- Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report
- Identification of DCAF1 by Clinical Exome Sequencing and Methylation Analysis as a Candidate Gene for Autism and Intellectual Disability: A Case Report
- Successful Treatment with High-Dose Immunoglobulin of a Complicated Patient with Catatonia and Central Nervous System Autoantibodies
- 165. Bridging Genetics and Psychiatry: ARID1B Haploinsufficiency in Autism Spectrum Disorder and Its Implications for C-L Psychiatry
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Molecular Dysregulation in Autism Spectrum Disorder
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- Molecular Dysregulation in Autism Spectrum Disorder
Similar Researchers
Based on overlapping research topics